Maximos OB/Gyn | League City, TX
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of the study is to evaluate the reactogenicity, safety, and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine, mRNA-1345, in pregnant women, and safety and immunogenicity in infants born to vaccinated mothers.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Maternal Participants
Specific inclusion criteria for Japanese pregnant women:
Infant Participants
Key Exclusion Criteria:
Maternal Participants
Infant Participants
Other inclusion and exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
360 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Moderna Clinical Trials Support Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal